Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults

SeVRSV is a replication-competent Sendai virus (SeV)-based vaccine carrying the respiratory syncytial virus (RSV) fusion protein (F) gene. Unmanipulated, non-recombinant SeV is a murine parainfluenza virus type 1 (PIV-1) and serves as a Jennerian vaccine for human PIV-1 (hPIV-1). SeV protects Africa...

Descripción completa

Detalles Bibliográficos
Autores principales: Scaggs Huang, Felicia, Bernstein, David I., Slobod, Karen S., Portner, Allen, Takimoto, Toru, Russell, Charles J., Meagher, Michael, Jones, Bart G., Sealy, Robert E., Coleclough, Christopher, Branum, Kristen, Dickey, Michelle, Buschle, Kristen, McNeal, Monica, Makowski, Mat, Nakamura, Aya, Hurwitz, Julia L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899675/
https://www.ncbi.nlm.nih.gov/pubmed/32750273
http://dx.doi.org/10.1080/21645515.2020.1779517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899675/
https://www.ncbi.nlm.nih.gov/pubmed/32750273
http://dx.doi.org/10.1080/21645515.2020.1779517

Ejemplares similares